NCT00080119 Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV Status TERMINATED Phase PHASE2/PHASE3
NCT00078247 Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis Status COMPLETED Phase PHASE3
NCT00052195 Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People Status COMPLETED Phase PHASE2/PHASE3
NCT00023452 Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection Status COMPLETED Phase PHASE3
NCT00023439 TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment Status COMPLETED Phase N/A
NCT00023426 TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis Status COMPLETED Phase PHASE2
NCT00023413 TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz Status COMPLETED Phase PHASE2
NCT00023400 TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB Status COMPLETED Phase PHASE4
NCT00023387 TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine Status COMPLETED Phase NA
NCT00023374 TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance Status COMPLETED Phase NA
NCT00023361 TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen Status COMPLETED Phase NA
NCT00023348 TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB Status COMPLETED Phase PHASE2/PHASE3
NCT00018083 Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen Status UNKNOWN Phase NA
NCT00005741 Indigenous Outreach Among Injection Drug Users to Treat and Control TB Status COMPLETED Phase N/A